Trial Profile
Efficacy of sorafenib in combination with allogeneic hematopoietic stem cell transplantation (HSCT) in patients with FLT3-ITD positive acute myeloid leukemia: A retrospective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Feb 2016
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 02 Feb 2016 New trial record